Investigation of Gene Regulation by NF-kappaB Transcription factors

NF-kappaB 转录因子基因调控的研究

基本信息

  • 批准号:
    8260199
  • 负责人:
  • 金额:
    $ 29.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-01 至 2013-10-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The NF-kappaB (NF-?B) family of dimeric transcription factors regulates diverse physiological processes including immune and inflammatory responses, cell proliferation and survival. The combinatorial NF-?B dimers are formed from five family members; p50, p52, RelA (p65), cRel and RelB. These dimers regulate transcription by binding to specific DNA sequences of target genes known as ?B sites. The long term goals of our laboratories are to understand how NF-?B dimers function specifically in gene regulation. To achieve that goal, we have pursued a variety of approaches ranging from the biophysical to the genetic. Recent studies have emphasized the role of post-translational modifications of NF-?B dimers and the role of dimer-specific co-activators in regulating specific target genes. The focus of this proposal is to examine transcriptional regulation by phosphorylation and coactivator recognition events. We employ genetic, genomic, biochemical and biophysical approaches to investigate the two NF-?B family members that play the most prominent roles in human disease: RelA and p52. In aim 1 experiments are designed to investigate the mechanisms of transcriptional control by the RelA:CBP/p300 complex. Several reports have demonstrated the importance of RelA phosphorylation, and CBP/p300 binding in target gene regulation. Other studies have revealed that the effect of this modification/interaction is not global. Each modification/interaction affects the expression of only a subset of genes in stimulus and cell type specific manner. In this study we will investigate the role of RelA phosphorylation and CBP/p300 interaction mechanism and its impact on gene regulation. In aim 2 Biophysical and in vivo experiments are designed to study the transcriptional control by the cancer-associated p52:Bcl3 complex. As homodimers, NF-?B p52 and p50 have been reported to associate with Bcl3 to activate transcription, and as such they play critical roles in immune organogenesis and tolerance. The goal of this aim is to investigate the molecular basis of how p52 homodimer associates with Bcl3 and the specificity of the interaction, and if these complexes target a subset of ?B sequences. Public Health Relevance: The NF-?B family of dimeric transcription activators, which regulates a large number of genes, is critical for maintaining normal cell physiology. The focus of this proposal is to understand the regulation of promoter and transcriptional coactivator recognition by the NF-?B dimers.
描述(由申请人提供):NF-κ B(NF-?B)二聚体转录因子家族调节多种生理过程,包括免疫和炎症反应、细胞增殖和存活。组合NF-?B二聚体由五个家族成员形成; p50、p52、RelA(p65)、cRel和RelB。这些二聚体通过与靶基因的特定DNA序列结合来调节转录。B位点。我们实验室的长期目标是了解NF-?B二聚体在基因调控中具有特异性功能。为了实现这一目标,我们采取了从生物物理到遗传的各种办法。最近的研究强调NF-κ B的翻译后修饰的作用?B二聚体和二聚体特异性共激活因子在调节特异性靶基因中的作用。这项建议的重点是研究磷酸化和辅激活因子识别事件的转录调控。我们采用遗传学,基因组学,生物化学和生物物理学的方法来研究这两个NF-?在人类疾病中发挥最重要作用的B家族成员:RelA和p52。在目的1中,设计实验来研究RelA:CBP/p300复合物的转录调控机制。一些报道已经证明了RelA磷酸化和CBP/p300结合在靶基因调控中的重要性。其他研究表明,这种修改/相互作用的影响不是全球性的。每个修饰/相互作用以刺激和细胞类型特异性方式仅影响基因的子集的表达。在本研究中,我们将探讨RelA磷酸化的作用和CBP/p300的相互作用机制及其对基因调控的影响。在目的2中,设计生物物理和体内实验来研究癌症相关的p52:Bcl 3复合物的转录控制。作为同源二聚体,NF-?据报道,B p52和p50与Bcl 3结合以激活转录,因此它们在免疫器官发生和耐受中起关键作用。本研究的目的是探讨p52同源二聚体与Bcl 3相互作用的分子基础及其特异性,以及这些复合物是否靶向Bcl 3亚群。B序列。公共卫生相关性:NF-?二聚体转录激活因子B家族调控大量基因,对维持细胞正常生理功能至关重要。这个建议的重点是了解启动子和转录辅激活因子识别的NF-?B二聚体。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GOURISANKAR GHOSH其他文献

GOURISANKAR GHOSH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GOURISANKAR GHOSH', 18)}}的其他基金

Chromogranin A is an aging risk factor
嗜铬粒蛋白 A 是衰老的危险因素
  • 批准号:
    10667265
  • 财政年份:
    2023
  • 资助金额:
    $ 29.65万
  • 项目类别:
Suppressing Inflammation by Blocking IKK Oligomer
通过阻断 IKK 寡聚物抑制炎症
  • 批准号:
    10446098
  • 财政年份:
    2022
  • 资助金额:
    $ 29.65万
  • 项目类别:
Suppressing Inflammation by Blocking IKK Oligomer
通过阻断 IKK 寡聚物抑制炎症
  • 批准号:
    10573218
  • 财政年份:
    2022
  • 资助金额:
    $ 29.65万
  • 项目类别:
Investigation of gene regulation by NF-kappaB transcription factors
NF-κB转录因子基因调控的研究
  • 批准号:
    9021868
  • 财政年份:
    2009
  • 资助金额:
    $ 29.65万
  • 项目类别:
Investigation of gene regulation by NF-kappaB transcription factors
NF-κB转录因子基因调控的研究
  • 批准号:
    8904029
  • 财政年份:
    2009
  • 资助金额:
    $ 29.65万
  • 项目类别:
IKK:Biophysical basis of dynamic regulation
IKK:动态调节的生物物理基础
  • 批准号:
    8072633
  • 财政年份:
    2009
  • 资助金额:
    $ 29.65万
  • 项目类别:
ASF/SF2: Phosphorylation and RNA Binding
ASF/SF2:磷酸化和 RNA 结合
  • 批准号:
    8130785
  • 财政年份:
    2009
  • 资助金额:
    $ 29.65万
  • 项目类别:
IKK:Biophysical basis of dynamic regulation
IKK:动态调节的生物物理基础
  • 批准号:
    8463406
  • 财政年份:
    2009
  • 资助金额:
    $ 29.65万
  • 项目类别:
Cofactor-Mediated DNA Binding by the NF-kappaB Dimers
NF-kappaB 二聚体辅助因子介导的 DNA 结合
  • 批准号:
    9887959
  • 财政年份:
    2009
  • 资助金额:
    $ 29.65万
  • 项目类别:
ASF/SF2: Phosphorylation and RNA Binding
ASF/SF2:磷酸化和 RNA 结合
  • 批准号:
    7907768
  • 财政年份:
    2009
  • 资助金额:
    $ 29.65万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 29.65万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 29.65万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.65万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.65万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 29.65万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.65万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 29.65万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 29.65万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 29.65万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.65万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了